• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

作者信息

Gersh Bernard J, Maron Barry J, Bonow Robert O, Dearani Joseph A, Fifer Michael A, Link Mark S, Naidu Srihari S, Nishimura Rick A, Ommen Steve R, Rakowski Harry, Seidman Christine E, Towbin Jeffrey A, Udelson James E, Yancy Clyde W

出版信息

J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.

DOI:10.1016/j.jacc.2011.06.011
PMID:22075469
Abstract
摘要

相似文献

1
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断和治疗指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告。与美国胸外科协会、美国超声心动图学会、美国核心脏病学会、美国心力衰竭学会、心律学会、心血管造影和介入学会以及胸外科医师学会合作制定。
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.
2
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.美国心脏病学会基金会适宜性使用标准专家组、心血管造影和介入学会、美国胸外科学会、美国心脏协会、美国超声心动图学会、美国核医学学会、美国心力衰竭学会、心律学会、重症医学会、心血管计算机断层扫描学会、心血管磁共振学会以及胸外科医师学会 2012 年诊断性心导管术适宜性使用标准：美国心脏病学会基金会适宜性使用标准专家组报告
J Am Coll Cardiol. 2012 May 29;59(22):1995-2027. doi: 10.1016/j.jacc.2012.03.003. Epub 2012 May 9.
3
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, Society of Thoracic Surgeons.ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012诊断性心导管插入术适用标准：美国心脏病学基金会适用标准工作组、心血管造影和介入学会、美国胸外科协会、美国心脏协会、美国超声心动图学会、美国核心脏病学会、美国心力衰竭学会、心律学会、危重病医学会、心血管计算机断层扫描学会、心血管磁共振学会、胸外科医师学会报告
J Thorac Cardiovasc Surg. 2012 Jul;144(1):39-71. doi: 10.1016/j.jtcvs.2012.04.013.
4
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 13;124(24):e783-831. doi: 10.1161/CIR.0b013e318223e2bd. Epub 2011 Nov 8.
5
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断和治疗指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1303-38. doi: 10.1016/j.jtcvs.2011.10.019.
6
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2011 Dec 13;124(24):2761-96. doi: 10.1161/CIR.0b013e318223e230. Epub 2011 Nov 8.
7
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011年美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Thorac Cardiovasc Surg. 2011 Dec;142(6):e153-203. doi: 10.1016/j.jtcvs.2011.10.020.
8
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.ACCF/SCAI/STS/AATS/AHA/ASNC 2009冠状动脉血运重建适宜性标准：美国心脏病学会基金会适宜性标准工作组、心血管造影和介入学会、胸外科医师学会、美国胸外科协会、美国心脏协会及美国核心脏病学会报告：得到美国超声心动图学会、美国心力衰竭学会和心血管计算机断层扫描学会认可。
Circulation. 2009 Mar 10;119(9):1330-52. doi: 10.1161/CIRCULATIONAHA.108.191768. Epub 2009 Jan 8.
9
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2011美国心脏病学会基金会/美国心脏协会肥厚型心肌病诊断与治疗指南：执行摘要：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2011 Dec 13;58(25):2703-38. doi: 10.1016/j.jacc.2011.10.825. Epub 2011 Nov 8.
10
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization : a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.ACCF/SCAI/STS/AATS/AHA/ASNC 2009冠状动脉血运重建适宜性标准：美国心脏病学会基金会适宜性标准工作组、心血管造影和介入学会、胸外科医师学会、美国胸外科协会、美国心脏协会及美国核心脏病学会的报告。经美国超声心动图学会、美国心力衰竭学会和心血管计算机断层扫描学会认可。
Catheter Cardiovasc Interv. 2009 Feb 15;73(3):E1-24. doi: 10.1002/ccd.21964.

引用本文的文献

1
Prognostic significance of FT3 levels in hypertrophic cardiomyopathy patients with HFpEF.FT3水平在射血分数保留的肥厚型心肌病患者中的预后意义。
Front Cardiovasc Med. 2025 Aug 21;12:1546309. doi: 10.3389/fcvm.2025.1546309. eCollection 2025.
2
Hypertensive heart disease: is it really a pathology?高血压性心脏病：它真的是一种病理学上的疾病吗？
Hypertens Res. 2025 Aug 4. doi: 10.1038/s41440-025-02312-x.
3
A pilot study on coronary microvascular dysfunction in obstructive hypertrophic cardiomyopathy: impact of percutaneous transluminal septal myocardial ablation.
梗阻性肥厚型心肌病冠状动脉微血管功能障碍的初步研究：经皮腔内室间隔心肌消融术的影响
Cardiovasc Interv Ther. 2025 Jun 27. doi: 10.1007/s12928-025-01154-1.
4
Applications of 3D Printing Technology in Diagnosis and Management of Heart Failure.3D打印技术在心力衰竭诊断与管理中的应用
Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):271-277. doi: 10.1007/s11936-024-01045-3. Epub 2024 Jun 21.
5
GEO combined with quantitative protein trait loci identify causative proteins in hypertrophic cardiomyopathy.基因表达综合数据库（GEO）与定量蛋白质性状位点相结合可鉴定肥厚型心肌病中的致病蛋白。
ESC Heart Fail. 2025 Aug;12(4):2827-2833. doi: 10.1002/ehf2.15287. Epub 2025 May 9.
6
TEER for SAM of the Mitral Valve and Flail Posterior Mitral Leaflet: 1-Clip Solution.二尖瓣SAM和二尖瓣后叶连枷的经食管超声心动图评估：单夹解决方案。
JACC Case Rep. 2024 Nov 15;30(1):102839. doi: 10.1016/j.jaccas.2024.102839. eCollection 2025 Jan 1.
7
Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology.肥厚型心肌病：特别关注马伐卡坦及其在心脏病学领域的未来发展
Biomedicines. 2024 Nov 24;12(12):2675. doi: 10.3390/biomedicines12122675.
8
Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者全免疫炎症指标的临床意义
Medeni Med J. 2024 Dec 27;39(4):254-260. doi: 10.4274/MMJ.galenos.2024.96266.
9
Three Novel Pathogenic Variants in Unrelated Vietnamese Patients with Cardiomyopathy.三名不相关的越南心肌病患者中的三种新型致病变体。
Diagnostics (Basel). 2024 Nov 30;14(23):2709. doi: 10.3390/diagnostics14232709.
10
Cardiac Myosin Inhibitors for Obstructive Hypertrophic Cardiomyopathy: A Meta-analysis of Randomized Placebo-Controlled Trials.用于梗阻性肥厚型心肌病的心肌肌球蛋白抑制剂：随机安慰剂对照试验的荟萃分析
Am J Cardiovasc Drugs. 2025 May;25(3):361-371. doi: 10.1007/s40256-024-00710-z. Epub 2024 Dec 16.